AfterGlow
Bluelighter
Drugwatch.com
February 21, 2011, 04:02 pm
The use of prescription amphetamines may increase an individual's risk of developing Parkinson's disease later in life, according to the results of a new study released Saturday.
The study followed 66,348 participants over an average period of 38.8 years. When patients initially enrolled in the study, they were asked if they had ever taken weight loss drugs, and more specifically, if they had ever taken the amphetamines Benzedrine or Dexedrine.
Researchers found that patients who had taken Benzedrine or Dexedrine developed Parkinson's disease at a higher rate than patients who admitted using weight-loss drugs but did not take the amphetamines.
The researchers, however, stressed that the study only suggests an association between Parkinson's disease and amphetamine use, not a causal relationship. Experts maintain further research is needed to assess the exact link between the two factors.
Amphetamines are psychostimulant drugs commonly used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy and, in some cases, obesity. They work by regulating the release and absorption of dopamine, a key chemical messenger that is often present in low levels in patients with Parkinson's disease.
Parkinson's disease is a chronic neurological illness that causes the progressive loss of movement control. The condition is one of the most prevalent neurological illnesses in the United States, second only to Alzheimer's disease.
link
February 21, 2011, 04:02 pm
The use of prescription amphetamines may increase an individual's risk of developing Parkinson's disease later in life, according to the results of a new study released Saturday.
The study followed 66,348 participants over an average period of 38.8 years. When patients initially enrolled in the study, they were asked if they had ever taken weight loss drugs, and more specifically, if they had ever taken the amphetamines Benzedrine or Dexedrine.
Researchers found that patients who had taken Benzedrine or Dexedrine developed Parkinson's disease at a higher rate than patients who admitted using weight-loss drugs but did not take the amphetamines.
The researchers, however, stressed that the study only suggests an association between Parkinson's disease and amphetamine use, not a causal relationship. Experts maintain further research is needed to assess the exact link between the two factors.
Amphetamines are psychostimulant drugs commonly used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy and, in some cases, obesity. They work by regulating the release and absorption of dopamine, a key chemical messenger that is often present in low levels in patients with Parkinson's disease.
Parkinson's disease is a chronic neurological illness that causes the progressive loss of movement control. The condition is one of the most prevalent neurological illnesses in the United States, second only to Alzheimer's disease.
link
